Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.
Condition: Breast Cancer Intervention: Sponsor: Pfizer Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials